Evidence for decreasing quality of semen during past 50 years

Clay-catalyzed ozonation of endocrine-disrupting compounds in solvent-free media - to better understand soil catalytic capacity

An original approach never tackled so far allowed correlating the basicity and hydrophilic character of clay catalysts to surface interaction with 17α-Ethinylestradiol (EE2) during ozonation in water. The clay catalysts were found to behave specifically according to their silica/alumina ratio like soils in natural oxidative processes. Acid-activated bentonites (HMt) and ion-exchanged montmorillonite (NaMt and Fe(ii)Mt) showed catalytic activity in the ozonation of 17α-ethinylestradiol (EE2) in aqueous media. In the absence of catalysts, the degradation of (EE2) reached 72% after one minute of ozonation and 99.5% after 60 minutes. In the presence of Fe(ii)Mt, EE2 degradation (96%) was achieved after only one minute of ozonation. Under similar conditions, almost total degradation to 99.99% was registered in 15 minutes of ozonation but without total mineralization of the intermediates. Moderately acid-activated bentonites exhibited higher activity affording total mineralization within a short period of ozonation. The catalytic activity of clay catalysts was found to correlate with their surface basicity and hydrophilic character. The results obtained herein allow understanding soil behavior in natural oxidative degradation of organic molecules and envisaging effective soil-based catalysts with surface properties judiciously tailored according to the nature of organic pollutants in solvent free media.

Environmental Chemical Assessment in Clinical Practice: Unveiling the Elephant in the Room

A growing body of evidence suggests chemicals present in air, water, soil, food, building materials and household products are toxicants that contribute to the many chronic diseases typically seen in routine medical practice. Yet, despite calls from numerous organisations to provide clinicians with more training and awareness in environmental health, there are multiple barriers to the clinical assessment of toxic environmental exposures. Recent developments in the fields of systems biology, innovative breakthroughs in biomedical research encompassing the "-omics" fields, and advances in mobile sensing, peer-to-peer networks and big data, provide tools that future clinicians can use to assess environmental chemical exposures in their patients. There is also a need for concerted action at all levels, including actions by individual patients, clinicians, medical educators, regulators, government and non-government organisations, corporations and the wider civil society, to understand the "exposome" and minimise the extent of toxic exposures on current and future generations. Clinical environmental chemical risk assessment may provide a bridge between multiple disciplines that uses new technologies to herald in a new era in personalised medicine that unites clinicians, patients and civil society in the quest to understand and master the links between the environment and human health.